Identification of an anti-MRSA dihydrofolate reductase inhibitor from a diversity-oriented synthesis
Authors:
- 10 September 2008
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- No. 40,p. 4962-4964
Abstract
The screening of a diversity-oriented synthesis library followed by structure–activity relationship investigations have led to the discovery of an anti-MRSA agent which operates as an inhibitor of Staphylococcus aureusdihydrofolate reductase.Keywords
This publication has 37 references indexed in Scilit:
- Gemmacin B: bringing diversity back into focusOrganic & Biomolecular Chemistry, 2008
- Chemical biology at the Broad InstituteNature Chemical Biology, 2007
- A call to armsNature Reviews Drug Discovery, 2006
- Where have all the antibiotic patents gone?Nature Biotechnology, 2006
- Bring the magic back to the bulletsNature Biotechnology, 2006
- Skeletal diversity construction via a branching synthetic strategyChemical Communications, 2006
- Small molecule screening by imagingCurrent Opinion in Chemical Biology, 2006
- Finding the target after screening the phenotypeDrug Discovery Today, 2005
- Synthesis of ethyl 2‐aminodihydro‐5‐pyrimidinecar‐boxylate derivatives and 3,7‐diethoxycarbonyl‐4,6‐dihydro‐2,4,6,8‐tetraaryl‐1H‐pyrimido[1,2‐a]pyrimidinesJournal of Heterocyclic Chemistry, 1997
- Mechanism of inhibition of dihydrofolate reductases from bacterial and vertebrate sources by various classes of folate analoguesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986